{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:02:26Z","timestamp":1779858146764,"version":"3.53.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL177797"],"award-info":[{"award-number":["R01HL177797"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL146802"],"award-info":[{"award-number":["R01HL146802"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR200947"],"award-info":[{"award-number":["PR200947"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR202411"],"award-info":[{"award-number":["PR202411"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"publisher","award":["T32IR5347"],"award-info":[{"award-number":["T32IR5347"]}],"id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejphar.2025.178058","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:52:02Z","timestamp":1755100322000},"page":"178058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Repurposing flavopiridol as an inhaled therapeutic for pulmonary fibrosis"],"prefix":"10.1016","volume":"1005","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4211-9988","authenticated-orcid":false,"given":"Ching-Hsien","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subash K.","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hsin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2657-745X","authenticated-orcid":false,"given":"David C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Yi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4063-0608","authenticated-orcid":false,"given":"Jihao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ssu-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper H.","family":"Yik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang-yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9947-9864","authenticated-orcid":false,"given":"Dominik R.","family":"Haudenschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178058_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","article-title":"Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways","volume":"139","author":"Alarcon","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178058_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.678559","article-title":"CDK9: a comprehensive review of its biology, and its role as a potential target for anti-cancer agents","volume":"11","author":"Anshabo","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2025.178058_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/21541264.2018.1523668","article-title":"CDK9: a signaling hub for transcriptional control","volume":"10","author":"Bacon","year":"2019","journal-title":"Transcription"},{"key":"10.1016\/j.ejphar.2025.178058_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.178058_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1097-2765(01)00314-8","article-title":"NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II","volume":"8","author":"Barboric","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2025.178058_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ki.2010.516","article-title":"Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases","volume":"79","author":"Barnes","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2025.178058_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109408","article-title":"Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseases","volume":"64","author":"Birnhuber","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2025.178058_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/ajrccm.157.1.9704130","article-title":"Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis","volume":"157","author":"Bjoraker","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.178058_bib9","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3389\/fimmu.2019.01597","article-title":"The influence of innate lymphoid cells and unconventional T cells in chronic inflammatory lung disease","volume":"10","author":"Borger","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178058_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/v12040472","article-title":"RSV reprograms the CDK9\u2217BRD4 chromatin remodeling complex to couple innate inflammation to airway remodeling","volume":"12","author":"Brasier","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ejphar.2025.178058_bib11","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI116052","article-title":"Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype","volume":"90","author":"Chen","year":"1992","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178058_bib12","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41467-020-16466-4","article-title":"Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity","volume":"11","author":"Cui","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.178058_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.stem.2017.03.011","article-title":"Two-way conversion between lipogenic and myogenic fibroblastic phenotypes marks the progression and resolution of lung fibrosis","volume":"20","author":"El Agha","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejphar.2025.178058_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/1389450119666181026152221","article-title":"CDK9 as an appealing target for therapeutic interventions","volume":"20","author":"Eyvazi","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2025.178058_bib15","doi-asserted-by":"crossref","first-page":"eaba1972","DOI":"10.1126\/sciadv.aba1972","article-title":"Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis","volume":"6","author":"Habermann","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2025.178058_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.joca.2018.11.006","article-title":"Inhibition of early response genes prevents changes in global joint metabolomic profiles in mouse post-traumatic osteoarthritis","volume":"27","author":"Haudenschild","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejphar.2025.178058_bib17","article-title":"Genetic and pharmacological inhibition of CDK9 drives neutrophil apoptosis to resolve inflammation in zebrafish in vivo","volume":"5","author":"Hoodless","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178058_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fphar.2018.00174","article-title":"Flavopiridol protects bone tissue by attenuating RANKL induced osteoclast formation","volume":"9","author":"Hu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178058_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.22203\/eCM.v030a14","article-title":"Inhibition of CDK9 prevents mechanical injury-induced inflammation, apoptosis and matrix degradation in cartilage explants","volume":"30","author":"Hu","year":"2016","journal-title":"Eur. Cell. Mater."},{"key":"10.1016\/j.ejphar.2025.178058_bib20","doi-asserted-by":"crossref","first-page":"14892","DOI":"10.18632\/aging.202998","article-title":"Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells","volume":"13","author":"Huang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejphar.2025.178058_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.434","article-title":"Coordinate activities of BRD4 and CDK9 in the transcriptional elongation complex are required for TGFbeta-induced Nox4 expression and myofibroblast transdifferentiation","volume":"8","author":"Ijaz","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.178058_bib22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1164\/ajrccm.157.4.9707039","article-title":"Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification","volume":"157","author":"Katzenstein","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.178058_bib23","doi-asserted-by":"crossref","DOI":"10.2460\/ajvr.24.03.0057","article-title":"Intra-articular injection of an extended-release flavopiridol formulation represents a potential alternative to other intra-articular medications for treating equine joint disease","volume":"85","author":"Katzman","year":"2024","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ejphar.2025.178058_bib24","doi-asserted-by":"crossref","DOI":"10.1242\/dev.199636","article-title":"Selective Cdk9 inhibition resolves neutrophilic inflammation and enhances cardiac regeneration in larval zebrafish","volume":"149","author":"Kaveh","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.ejphar.2025.178058_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/329481","article-title":"Pharmacological treatment of idiopathic pulmonary fibrosis: current approaches, unsolved issues, and future perspectives","volume":"2015","author":"Kreuter","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2025.178058_bib26","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178058_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12931-023-02421-6","article-title":"Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis","volume":"24","author":"Li","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.ejphar.2025.178058_bib28","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ymthe.2021.01.028","article-title":"Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2025.178058_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/phy2.249","article-title":"A mouse model of chronic idiopathic pulmonary fibrosis","volume":"2","author":"Limjunyawong","year":"2014","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.ejphar.2025.178058_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2025.178058_bib31","doi-asserted-by":"crossref","first-page":"13084","DOI":"10.1074\/jbc.M111.288944","article-title":"Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor beta (TGF-beta1) signaling axis","volume":"287","author":"Mascareno","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178058_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.905315","article-title":"Inhibition of cyclin-dependent kinase 9 downregulates cytokine production without detrimentally affecting human monocyte-derived macrophage viability","volume":"10","author":"McHugh","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.178058_bib33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1165\/rcmb.2019-0396OC","article-title":"FOXL1 regulates lung fibroblast function via multiple mechanisms","volume":"63","author":"Miyashita","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.178058_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nchembio.90","article-title":"A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity","volume":"4","author":"Montagnoli","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2025.178058_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1183\/09059180.00002512","article-title":"Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature","volume":"21","author":"Nalysnyk","year":"2012","journal-title":"Eur. Respir. Rev. : an official journal of the European Respiratory Society"},{"key":"10.1016\/j.ejphar.2025.178058_bib36","article-title":"Production of inhalable ultra-small particles for delivery of anti-inflammation medicine via a table-top microdevice","volume":"13","author":"Owen","year":"2022","journal-title":"Micromachines (Basel)"},{"key":"10.1016\/j.ejphar.2025.178058_bib37","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1007\/s00018-019-03212-3","article-title":"Molecular determinants of mesenchymal cell activation in fibroproliferative diseases","volume":"76","author":"Penke","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2025.178058_bib38","doi-asserted-by":"crossref","first-page":"286S","DOI":"10.1378\/chest.122.6_suppl.286S","article-title":"The myofibroblast in pulmonary fibrosis","volume":"122","author":"Phan","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2025.178058_bib39","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/ki.2015.235","article-title":"The Smad3\/Smad4\/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction","volume":"88","author":"Qu","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2025.178058_bib40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0041-008X(73)90261-5","article-title":"An improved apparatus for acute inhalation exposure of rodents to radioactive aerosols","volume":"26","author":"Raabe","year":"1973","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178058_bib41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1164\/ajrccm\/138.3.703","article-title":"Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs","volume":"138","author":"Raghu","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ejphar.2025.178058_bib42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1165\/rcmb.2006-0178OC","article-title":"Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts","volume":"36","author":"Sanders","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.178058_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/ATVBAHA.110.213934","article-title":"Flavopiridol protects against inflammation by attenuating leukocyte-endothelial interaction via inhibition of cyclin-dependent kinase 9","volume":"31","author":"Schmerwitz","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178058_bib44","first-page":"1143","article-title":"Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy","volume":"9","author":"Sedlacek","year":"1996","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2025.178058_bib45","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4049\/jimmunol.180.3.1954","article-title":"Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors","volume":"180","author":"Sekine","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2025.178058_bib46","doi-asserted-by":"crossref","first-page":"4270s","DOI":"10.1158\/1078-0432.CCR-040020","article-title":"Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol","volume":"10","author":"Shapiro","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.178058_bib47","doi-asserted-by":"crossref","first-page":"L1183","DOI":"10.1152\/ajplung.00224.2016","article-title":"BRD4 mediates NF-kappaB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation","volume":"311","author":"Tian","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejphar.2025.178058_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15586\/aei.v49i6.451","article-title":"MiR-224 ameliorates inflammation and symptoms in mouse model of allergic rhinitis by targeting CDK9","volume":"49","author":"Wang","year":"2021","journal-title":"Allergol. Immunopathol. (Madr)"},{"key":"10.1016\/j.ejphar.2025.178058_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.178058_bib50","article-title":"The role of immune cells in the pathogenesis of idiopathic pulmonary fibrosis","volume":"59","author":"Xu","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ejphar.2025.178058_bib51","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1096\/fj.201901705R","article-title":"Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression","volume":"33","author":"Yang","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2025.178058_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apcsb.2016.11.001","article-title":"Targeting chromatin remodeling in inflammation and fibrosis","volume":"107","author":"Yang","year":"2017","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.ejphar.2025.178058_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115465","article-title":"CDK9 inhibition improves diabetic nephropathy by reducing inflammation in the kidneys","volume":"416","author":"Yang","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178058_bib54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S1097-2765(03)00388-5","article-title":"Inhibition of P-TEFb (CDK9\/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA","volume":"12","author":"Yik","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2025.178058_bib55","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/art.38378","article-title":"Cyclin-dependent kinase 9 inhibition protects cartilage from the catabolic effects of proinflammatory cytokines","volume":"66","author":"Yik","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejphar.2025.178058_bib56","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1345\/aph.1A162","article-title":"Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development","volume":"36","author":"Zhai","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178058_bib57","doi-asserted-by":"crossref","first-page":"23505","DOI":"10.18632\/oncotarget.25239","article-title":"The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells","volume":"9","author":"Zocchi","year":"2018","journal-title":"Oncotarget"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500812X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992500812X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:13:27Z","timestamp":1779855207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992500812X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":57,"alternative-id":["S001429992500812X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178058","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing flavopiridol as an inhaled therapeutic for pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178058"}}